远程程控在心脏置入型电子器械术后随访中的可行性和安全性初探

Feasibility and safety of remote programming in postoperative follow-up of cardiovascular implantable electronic devices

目的探索基于5G云技术支持平台的远程程控技术在心脏置入型电子器械(CIED)术后随访中的可行性和安全性。方法本研究为多中心横断面研究。选取2021年6至10月在四川省12家暂缺随访专员的综合医院的CIED置入患者,由成都市第三人民医院远程随访中心的随访专员通过5G云技术支持平台对患者器械进行实时远程检查和远程程控。收集患者的基线资料、器械报警事件、再程控事件、不良反应及满意度问卷调查结果。结果共纳入195例CIED置入患者,年龄(72.5±11.3)岁,男性103例(52.6%),所有患者均成功完成远程检查和程控,用时(5.8±4.0)min。根据随访结果,91例患者的CIED需要再程控,累计参数调整104次。所有程控过程通信情况无异常,患者未发生任何不良事件。满意度问卷调查显示,97.9%(191/195)的患者信任或比较信任远程随访,86.7%(169/195)的患者愿意选择远程随访模式进行设备管理。结论基于5G云技术支持平台的远程程控技术在CIED患者术后随访中的临床应用可能是可行、安全的。

Objective To explore the feasibility and safety of remote programming technology based on 5G cloud technology support platform in postoperative follow-up of cardiovascular implantable electronic devices(CIED).Methods This study was a multicenter cross-sectional study.CIED patients from 12 hospitals lacking full-time follow-up specialists in Sichuan Province were enrolled from June 2021 to October 2021.All patients′devices received remote inspecting and programming by the follow-up specialist of the remote follow-up center of the Third People′s Hospital of Chengdu through 5G cloud technology support platform.The baseline data,device alarm events,device reprogramming events,adverse reactions and satisfaction questionnaire survey results were collected.Results A total of 195 CIED implantation patients were included,with an age of(72.5±11.3)years,including 103 males(52.6%).All patients completed remote inspecting and programming successfully,with a duration of(5.8±4.0)min.Ninety-one patients′CIED were reprogrammed,with a total of 104 parameter adjustments.No abnormal communication or adverse events occurred.The satisfaction questionnaire showed that 97.9%(191/195)of the patients trusted or relatively trusted remote follow-up and 86.7%(169/195)of the patients were willing to choose remote follow-up mode for device management.Conclusion The remote programming based on 5G cloud technology support platform may be feasible and safe for postoperative follow-up of CIED patients.